Breast Biopsy Market- Industry Overview and Key Factors
Breast Biopsy tests are used largely for diagnosing breast cancer and also as a preventive checkup for breast cancer and other ailments in the breast, such as lump etc. identified during physical examination. The Breast Biopsy market can be segmented based on technique type. The various different techniques for Breast Biopsy are Fine needle aspiration biopsy, which is one of the minimal invasive procedure, usually without scarring.
Transparency Market Research, in a report titled “Breast Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” studies the scope and dynamics of the global breast biopsy market. The report highlights the key factors driving the market from 2015 to 2023, identifies the major roadblocks that could hamper the expansion of the global market, and studies the current and future trends that are likely to present lucrative opportunities for the market players.
The global breast biopsy market is driven by the rising incidence of breast cancer, the growing level of awareness, the increased prevalence of breast cancer among post-menopausal women, and the technological advancement in cancer screening. In contrast, the high cost of the procedure is a major deterrent to the growth of the breast biopsy market. Moreover, given that the demand for the procedure is skewed towards a particular gender and age group, it eliminates a massive portion of the global population. This also acts as a restraint for the breast biopsy market.
The various types of breast biopsies include fine-needle aspiration, vacuum-assisted, incisional, needle biopsy, core-needle, open surgical, and excisional. The products used to perform a breast biopsy include biopsy tables, biopsy needles, localization wires, guidance systems, punches, markers, and sutures. A breast biopsy can be performed with the guidance of ultrasound, mammogram, MRI, and others such as thermography and PET scan.
The US is a major market for breast biopsies, mainly because breast cancer is the most common cancer among women in the US. In 2012 alone, an estimated 224,147 women and 2,125 men in the country were diagnosed with breast cancer, of which 41,150 women and 405 men died from the disease. This alarming rise in the incidence of breast cancer is one of the most significant factors boosting the US breast biopsy market. In addition to this, the surge in reimbursement rates in the country for image-guided biopsy has also positively impacted the breast biopsy market in the US.
Browse Full Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7150
Some of the leading participants in the breast biopsy market are Laboratory Corporation of America Holdings (Labcorp), Intact Medical, Hologic Inc., Cook Medical Incorporated, Biomed Diagnostics, Inc., C.R. Bard, Inc., Argon Medical Devices, Ethicon Endo Surgery (Johnson and Johnson), Devicor Medical Products Inc., Mammotome, Galini SRL, Encapsule Medical Devices LLC, Bard Peripheral Vascular Inc., F. Hoffmann-La Roche Ltd., OncoCyte Corporation, and Becton, Dickinson and Company. These players are profiled in the report based on attributes such as company and financial overview, recent developments, and business strategies.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
Source: Free Articles from ArticlesFactory.com
ABOUT THE AUTHOR
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.